Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular Lymphoma.
Narita H, Kuroiwa K, Kawaguchi Y, Murai S, Sasaki Y, Homma M, Kawamata N, Hayashi H, Nagao K, Okamura R, Uesugi Y, Sasaki Y, Shimada S, Watanuki M, Arai N, Yanagisawa K, Shiozawa E, Yamochi T, Hattori N. Narita H, et al. Among authors: shiozawa e. Int J Mol Sci. 2024 Oct 15;25(20):11057. doi: 10.3390/ijms252011057. Int J Mol Sci. 2024. PMID: 39456838 Free PMC article.
Clinicopathological differences in MYC and BCL2 protein expression between primary extranodal and nodal diffuse large B-cell lymphoma.
Sasaki Y, Murai S, Hayashi H, Kawamata N, Nagao K, Kuroiwa K, Narita H, Okamura R, Shimada S, Watanuki M, Arai N, Kawaguchi Y, Yanagisawa K, Shiozawa E, Yamochi T, Hattori N. Sasaki Y, et al. Among authors: shiozawa e. Pathol Res Pract. 2024 Aug;260:155425. doi: 10.1016/j.prp.2024.155425. Epub 2024 Jun 25. Pathol Res Pract. 2024. PMID: 38964118
Histopathological bone marrow changes after reduced-intensity hematopoietic stem cell transplantation for follicular lymphoma involving bone marrow.
Maeda T, Shiozawa E, Saito B, Usui T, Nakashima H, Hattori N, Adachi D, Yanagisawa K, Kawakami K, Nakamaki T, Tomoyasu S, Yamochi-Onizuka T, Takimoto M, Ota H. Maeda T, et al. Among authors: shiozawa e. Pathol Int. 2007 Jun;57(6):378-82. doi: 10.1111/j.1440-1827.2007.02110.x. Pathol Int. 2007. PMID: 17539969
Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia.
Arai N, Homma M, Abe M, Baba Y, Murai S, Watanuki M, Kawaguchi Y, Fujiwara S, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Hattori N, Saito B, Shiozawa E, Harada H, Yamochi-Onizuka T, Nakamaki T, Takimoto M. Arai N, et al. Among authors: shiozawa e. Int J Hematol. 2019 May;109(5):539-544. doi: 10.1007/s12185-019-02616-y. Epub 2019 Mar 7. Int J Hematol. 2019. PMID: 30847774 Clinical Trial.
Ki-67 expression of immunohistochemistry using computerized image analysis is a useful prognostic marker in follicular lymphomas.
Kawaguchi Y, Shiozawa E, Shimada S, Sasaki Y, Abe M, Murai S, Baba Y, Arai N, Okamoto N, Kabasawa N, Homma M, Saito B, Yamochi-Onizuka T, Nakamaki T, Takimoto M. Kawaguchi Y, et al. Among authors: shiozawa e. Int J Clin Exp Pathol. 2018 Jul 1;11(7):3366-3374. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31949713 Free PMC article.
Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Kabasawa N, Shiozawa E, Murai S, Homma M, Uesugi Y, Matsui T, Nakata A, Shimada S, Sasaki Y, Baba Y, Watanuki M, Arai N, Fujiwara S, Kawaguchi Y, Tsukamoto H, Uto Y, Yanagisawa K, Hattori N, Sakai H, Harada H, Nakamaki T, Takimoto M, Yamochi-Onizuka T. Kabasawa N, et al. Among authors: shiozawa e. J Clin Exp Hematop. 2021;61(3):120-125. doi: 10.3960/jslrt.20025. J Clin Exp Hematop. 2021. PMID: 34511544 Free PMC article.
46 results